
About this episode
Scott Crofton, Partner at Sullivan & Cromwell LLP
Too often, M&A involves a larger entity acquiring a smaller business. Only a few believe that a merger of equal can be possible, especially considering the power struggle between the two companies. However, a merger of equals can be a powerful strategy that could unlock tremendous value and opportunities for growth if done right.
In this episode of the M&A Science Podcast, Scott Crofton, Partner at Sullivan & Cromwell LLP, discusses the path to a successful equal merger.
____________________________________________________________________________
This episode is sponsored by the M&A Science Academy. If you're looking to improve your in-house training, we have corporate training plans provided.
Give your team members access to the best in class courses, templates, and networking opportunities in the industry. Our academy was designed to lead practitioners with the outdo with the M&A practices. It's also a great way to show your support for M&A Science.
If you're interested in learning more about individual or team plans, visit this page.
Episode Timestamps
00:00 Intro
04:27 Mergers of equal
07:05 Managing mergers of equal
09:13 Private deals
12:55 The management team under mergers of equals
14:33 Board of directors composition
16:12 The process of mergers of equals
19:27 Diligence process
20:55 The impact of mergers of equal
23:06 Real-life story of Hostile Bids
25:13 Poison pill defense
28:51 Fairness Analysis
31:31 Litigation
33:18 Pros and Cons of Mergers of Equal
35:06 Time frame of mergers of equal
35:57 Best Advice
36:59 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science

Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science

Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science

Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science

Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science